Skip to main content
. 2023 Aug 3;13(8):e068811. doi: 10.1136/bmjopen-2022-068811

Table 2.

Frequency of self-reported glaucoma medications prescribed among the GOG participants

Drug (brand) Count Percentage
Latanoprost (APO-Latanoprost, Lanpro, Latanoprost Actavis, Latanoprost GH, Latanoprost Sandoz, Xalaprost, Xalatan) 2369 54
Bimatoprost (Lumigan PF) 691 16
Travoprost (Travatan) 609 14
Timolol (Timoptol, Timoptol XE, Nyogel) 756 17
Timolol+dorzolamide (APO-Dorzolamide/Timolol, Cosdor, DORZOLAMIDE/TIMOLOL AN, Cosopt, Cosopt PF) 256 6
Timolol+Travoprost (Duotrav) 611 14
Timolol+Latanoprost (APO-Latanoprost/Timolol, Lantim, Latanoprost/Timolol Sandoz, Latanoprost/timolol AN, Xalacom, Xalamol) 681 16
Timolol+Bimatoprost (GANfort PF, Ganfort) 788 18
Timolol+Brimonidine (Combigan) 233 5
Timolol+Brinzolamide (Azarga) 232 5
Brimonidine (Alphagan P, Alphagan, Enidin) 508 12
Apraclonidine (Iopidine) 31 0.7
Dorzolamide (APO-Dorzolamide, Trusamide, Trusopt) 137 3
Brinzolamide (BrinzoQuin, Azopt) 609 14
Brinzolamide+brimonidine (Simbrinza) 367 8
Acetazolamide (Diamox) 178 4
Betaxolol (BetoQuin, Betoptic) 42 0.96
Pilocarpine (Isopto Carpine) 113 3
Tafluprost (Saflutan) 149 3
Other 79 2

This table shows the number and percentage of participants who had a prescription filled for at least one of the 19 commonly used glaucoma drugs. Note that the total count does not sum up to 4393 (the overall number of respondents) because some participants had used various combinations of these drugs.

GOG, Genetics of Glaucoma.